Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FHY0D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $328,596
Award facts
- Contract value 100% obligated
- $328,595.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $328,595.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors, with an ultimate completion date of October 23, 2025. This non-set-aside contract represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor, which serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion and extending through December 2026, which provides a comprehensive global pharmaceutical support vehicle for the delivery of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains.
AmerisourceBergen's substantial prime contract with the Defense Logistics Agency demonstrates the company's established capability to meet federal medical supply requirements through open competition and delivers critical pharmaceutical products to support military healthcare programs worldwide. As a major pharmaceutical distributor and healthcare solutions provider, the company regularly fulfills delivery orders for specialty medications and medical commodities serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This Dupixent delivery order exemplifies the type of biopharmaceutical procurement that supports the military health system's treatment capabilities for conditions such as atopic dermatitis and other inflammatory diseases.
Quick answers
Who was awarded contract SPE2DR26FHY0D?
SPE2DR26FHY0D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DR26FHY0D worth?
The government has obligated $328,596 on SPE2DR26FHY0D.
Is contract SPE2DR26FHY0D an order under another contract?
Yes. SPE2DR26FHY0D is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FHY0D competed?
The extent of competition for SPE2DR26FHY0D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award